# ACUT (Accustem Sciences, Inc.) - SEC EDGAR Financial Statements

> Accustem Sciences, Inc. reported $83K in total assets and a net loss of $3.12M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ACUT
- Markdown: https://convexityos.com/fundamentals/ACUT.md
- SEC CIK: 0001850767
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:12 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001850767&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$3.12M | Operating profit |
| Net Income | FY 2025 | -$3.12M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.19 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $15K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Research & Development | $281K | $138K | $140K | $267K | $73K |
| Total Operating Expenses | $1.76M | $1.51M | $2.05M | $3.75M | $671K |
| **Operating Income** | -$1.76M | -$1.51M | -$2.05M | -$3.75M | -$671K |
| **EBITDA** | -$1.76M | -$1.50M | -$2.05M | -$3.74M | -- |
| Income Before Tax | -$1.76M | -$1.51M | -$2.05M | -$3.75M | -$671K |
| **Net Income** | -$1.76M | -$1.51M | -$2.05M | -$3.75M | -$671K |
| Basic EPS | -$0.12 | -$0.13 | -$0.18 | -$0.34 | -$0.07 |
| **Diluted EPS** | -$0.12 | -$0.13 | -$0.18 | -$0.34 | -- |
| Basic Shares Outstanding | 15.2M | 11.4M | 11.3M | 11.0M | 10.0M |
| Diluted Shares Outstanding | 15.2M | 11.4M | 11.3M | 11.0M | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | $98K | -- | -- | -- | -- | -- | -- |
| Research & Development | $14K | $44K | $120K | $120K | $73K | $60K | $28K | $42K |
| Total Operating Expenses | $1.87M | $351K | $486K | $514K | $400K | $401K | $440K | $372K |
| **Operating Income** | -$1.87M | -$253K | -$486K | -$514K | -$400K | -$401K | -$440K | -$372K |
| **EBITDA** | -- | -- | -- | -$514K | -$400K | -$401K | -$440K | -$371K |
| Income Before Tax | -- | -- | -$486K | -$514K | -$400K | -$401K | -$440K | -$372K |
| **Net Income** | -$1.87M | -$253K | -$486K | -$514K | -$400K | -$401K | -$440K | -$372K |
| Basic EPS | -$0.12 | -$0.02 | -$0.03 | -- | -$0.02 | -$0.02 | -$0.03 | -- |
| **Diluted EPS** | -$0.12 | -$0.02 | -$0.03 | -- | -$0.02 | -$0.02 | -$0.03 | -- |
| Basic Shares Outstanding | 16.1M | 16.1M | 16.1M | -- | 16.1M | 16.1M | 12.7M | -- |
| Diluted Shares Outstanding | 16.1M | 16.1M | 16.1M | -- | 16.1M | 16.1M | 12.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $14K | $5.0K | $21K | $734K | -- |
| **Cash & Short-Term Investments** | $14K | $5.0K | $21K | $734K | -- |
| Other Current Assets | -- | -- | -- | $30K | -- |
| **Total Current Assets** | $49K | $50K | $130K | $932K | $1.35M |
| Property, Plant & Equipment, Net | -- | $418 | $4.0K | $7.7K | -- |
| **Total Non-Current Assets** | $1.50M | $418 | $4.0K | $7.7K | $0 |
| **Total Assets** | $1.55M | $51K | $134K | $940K | $1.35M |
| Accounts Payable | $704K | $805K | $578K | $312K | $389K |
| Other Current Liabilities | $4.22M | $2.37M | $1.45M | $142K | -- |
| **Total Current Liabilities** | $4.95M | $3.36M | $2.25M | $1.08M | $703K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $4.95M | $3.36M | $2.25M | $1.08M | $703K |
| Common Stock | $16K | $12K | $11K | $11K | $10.0K |
| Retained Earnings | -$9.78M | -$8.03M | -$6.52M | -$4.47M | -$725K |
| Accumulated Other Comp. Income | -- | -- | -- | -- | $67K |
| **Total Stockholders' Equity** | -$3.40M | -$3.31M | -$2.11M | -$140K | $651K |
| Total Equity | -$3.40M | -$3.31M | -$2.11M | -$140K | $651K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $15K | $13K | $12K | $14K | $14K | $31K | $36K | $5.0K |
| **Cash & Short-Term Investments** | $15K | $13K | $12K | $14K | $14K | $31K | $36K | $5.0K |
| Other Current Assets | -- | -- | -- | -- | $1.50M | $1.50M | $1.50M | -- |
| **Total Current Assets** | $83K | $106K | $50K | $49K | $1.57M | $1.61M | $1.55M | $50K |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | $105 | $418 |
| **Total Non-Current Assets** | $0 | $1.50M | $1.50M | $1.50M | $0 | $0 | $105 | $418 |
| **Total Assets** | $83K | $1.61M | $1.55M | $1.55M | $1.57M | $1.61M | $1.55M | $51K |
| Accounts Payable | $640K | $616K | $738K | $704K | $923K | $860K | $849K | $805K |
| Other Current Liabilities | $5.36M | $5.02M | $4.68M | $4.22M | $3.37M | $3.07M | $2.71M | $2.37M |
| **Total Current Liabilities** | $6.06M | $5.72M | $5.42M | $4.95M | $4.48M | $4.15M | $3.71M | $3.36M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $6.06M | $5.72M | $5.42M | $4.95M | $4.48M | $4.15M | $3.71M | $3.36M |
| Common Stock | $16K | $16K | $16K | $16K | $16K | $16K | $16K | $12K |
| Retained Earnings | -$12.39M | -$10.52M | -$10.27M | -$9.78M | -$9.27M | -$8.87M | -$8.47M | -$8.03M |
| **Total Stockholders' Equity** | -$5.98M | -$4.12M | -$3.87M | -$3.40M | -$2.91M | -$2.53M | -$2.16M | -$3.31M |
| Total Equity | -$5.98M | -$4.12M | -$3.87M | -$3.40M | -$2.91M | -$2.53M | -$2.16M | -$3.31M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$1.76M | -$1.51M | -$2.05M | -$3.75M | -$671K |
| Depreciation & Amortization | $418 | $3.6K | $3.6K | $3.3K | -- |
| Stock-Based Compensation | $89K | $70K | $79K | $134K | $21K |
| Change in Payables | -$101K | $226K | $267K | -$77K | $395K |
| **Operating Cash Flow** | -$850K | -$664K | -$1.62M | -$1.81M | -- |
| Capital Expenditure | -- | -- | -- | -$11K | -- |
| **Free Cash Flow** | -- | -- | -- | -$1.82M | -- |
| **Investing Cash Flow** | -- | -- | -- | -$11K | -- |
| Common Stock Issued | -- | -- | -- | $2.68M | -- |
| **Financing Cash Flow** | $859K | $648K | $903K | $2.55M | -- |
| **Net Change in Cash** | $8.9K | -$16K | -$712K | $734K | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.87M | -$253K | -$486K | -$514K | -$400K | -$401K | -$440K | -$372K |
| Depreciation & Amortization | -- | -- | -- | $0 | $105 | $105 | $313 | $907 |
| Stock-Based Compensation | $7.4K | $7.3K | $15K | $24K | $24K | $23K | $18K | $19K |
| Change in Payables | $24K | -$122K | $34K | -$219K | $63K | $11K | $44K | $14K |
| **Operating Cash Flow** | -$241K | -$249K | -$374K | $22K | -$604K | $22K | -$290K | $414 |
| **Financing Cash Flow** | $244K | $250K | $372K | -$23K | $587K | -$27K | $322K | -$32K |
| **Net Change in Cash** | $2.4K | $721 | -$1.7K | -$463 | -$17K | -$5.0K | $31K | -$32K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -- | -- | -103.1% |
| Return on Assets (ROA) | -113.3% | -2959.8% | -1531.5% | -398.7% | -49.6% |
| Current Ratio | 0.01x | 0.01x | 0.06x | 0.86x | 1.93x |
| Quick Ratio | 0.00x | 0.00x | 0.01x | 0.68x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -3753.2% | -102.9% | -116.3% | -113.3% | -102.6% | -95.6% | -91.5% | -2959.8% |
| Current Ratio | 0.01x | 0.02x | 0.01x | 0.01x | 0.35x | 0.39x | 0.42x | 0.01x |
| Quick Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.00x |
| Operating Cash Flow Growth (YoY) | -- | -1253.8% | -- | +5300.2% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
